Top Markets
#1 MowCat MowCat +49.48%
#2 Velvet Velvet +22.01%
#3 Block Street Block Street +17.94%
#4 Perle Perle +17.51%
#5 Quack AI Quack AI +16.48%
#6 Fake World Assets Fake World Assets +16.44%
#7 Derive Derive +14.43%
#8 Bermuda Shorts Bermuda Shorts +13.97%
#9 Epic Chain Epic Chain +13.90%
#10 DUSK Network DUSK Network +12.90%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Eargo, Inc. Eargo, Inc.

Eargo, Inc.

EAR
Rank in Stocks #34758
Eargo, Inc., a medical device firm, strives to improve the quality of life for... Eargo, Inc., a medical device firm, strives to improve the quality of life for individuals experiencing hearing impairment across the United States. The company focuses on developing and distributing hearing aids, utilizing both direct-to-consumer and extensive omni-channel sales approaches. Founded in 2010, the organization initially operated as Aria Innovations, Inc., before officially changing its name to Eargo, Inc. in November 2014. Its primary corporate hub is located in San Jose, California.
Share Price
$2.57
Last synced: 2024-02-23
Market Cap
$4.99M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Eargo, Inc. (EAR)

Category

Healthcare
Revenue for Eargo, Inc. (EAR)
Revenue in Aug 2026 TTM: 0
According to Eargo, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Eargo, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US